Skip to main content

Anastrozole Cardiovascular Risk

Meaning

Anastrozole Cardiovascular Risk refers to the potential for adverse effects on the heart and circulatory system associated with the use of the aromatase inhibitor drug anastrozole. This risk encompasses various cardiovascular events, including an increased incidence of ischemic heart disease, hypertension, and hypercholesterolemia, particularly in susceptible populations. Clinicians must carefully weigh the endocrine benefits of estrogen suppression against the potential for these systemic complications when prescribing this medication. Monitoring a patient’s lipid profile and blood pressure is an essential component of clinical risk management during anastrozole therapy.